# Rexulti

NDC: 75929-273
Generic name: brexpiprazole
Labeler / Manufacturer: Pharma Packaging Solutions, LLC dba Tjoapack LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20150710

FDA application: NDA205422

## Active ingredients

- BREXPIPRAZOLE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75929-273"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75929-273